secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immix Biopharma, Inc. (IMMX)
CIK:        0001873835
Form:       8-K
Filed at:   2022-06-09T23:59:59+00:00
Accession:  0001493152-22-016237
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Immix Biopharma stockholders elect seven directors, ratify auditor at annual meeting
--------------------------------------------------------------------------------

- All seven director nominees elected: Ilya Rachman, Gabriel Morris, Jason Hsu, Magda Marquet, Helen C. Adams, Carey Ng, Jane Buchan.
- Ratification of KMJ Corbin & Company LLP as independent auditor approved with 9,023,287 for, 1,213,599 against, 11,599 abstain.
- Total shares represented at meeting: 10,248,485, constituting a quorum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1873835/000149315222016237/0001493152-22-016237-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1873835/000149315222016237/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-016237

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer